Advertisement
Advertisement
U.S. Markets close in 1 hr 57 mins
Advertisement
Advertisement
Advertisement
Advertisement

BioVie Inc. (BIVI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.2900-0.3000 (-6.54%)
As of 01:49PM EST. Market open.
Advertisement

BioVie Inc.

2120 Colorado Avenue
Suite 230
Santa Monica, CA 90404
United States
312 283 5793
https://www.biovieinc.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees6

Key Executives

NameTitlePayExercisedYear Born
Mr. Cuong Viet Do M.B.A., MBAPres, CEO & DirectorN/AN/A1966
Ms. Joanne Wendy Kim CPACFO & Corp. Sec.120.62kN/A1955
Mr. Jonathan M. Adams M.B.A., MBAExec. VP of Liver Disease Program267.2kN/A1963
Dr. Penelope Markham Ph.D.Exec. VP of Liver Disease R&DN/AN/A1966
Ms. Denise SmithSr. VP of Manufacturing & Devel.N/AN/AN/A
Dr. Christopher L. Reading Ph.D.Exec. VP of Neuroscience R&DN/AN/A1948
Mr. Clarence N. AhlemExec. VP of Neuroscience Product Devel.N/AN/AN/A
Dr. Joseph M. Palumbo M.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Santa Monica, California.

Corporate Governance

BioVie Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement